Answers are grounded in this paper and cite their sources.
Develops a unified hierarchical outcomes tree for congenital malformations, enhancing risk detection across coding eras.
Composite major congenital malformation (MCM) outcomes are commonly used to assess teratogenic effects of prenatal medication exposure, but this approach dilutes effect estimates when the risk is confined to a specific MCM. Tree-based scan statistics address this by screening outcomes using a hierarchical tree, enabling detection of specific risks without predefined hypotheses. To apply this method across ICD-9-CM and ICD-10-CM eras, we developed a unified hierarchical outcomes tree for MCM. We selected ICD-9-CM and ICD-10-CM codes classified as congenital anomalies, removing minor malformations, chromosomal anomalies, and single-gene conditions. A multi-level tree was built based on the Multilevel Clinical Classification Software, General Equivalence Mappings, and expert review. We validated the tree using birth cohorts from MarketScan and Medicaid databases (2011-2013; 2016-2018), assessing balance of MCM prevalences within one year of birth via standardized mean differences (SMDs). The final tree included 1023 codes, organized into 244 clinical MCM groups at the most granular level. We identified 572 107 (2011-2013) and 360 167 infants (2016-2018) in MarketScan and 362 820 and 3 500 589 infants in Medicaid. All SMDs were below 0.1, indicating consistency across coding eras. This hierarchical MCM tree bridges ICD-9-CM and ICD-10-CM, enabling consistent outcome definitions and enhancing detection of specific teratogenic risks.
No takes yet. Share an insight, caveat, or question.
Thai et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: